Cargando…
Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy
BACKGROUND: The malignant pleural mesothelioma (MPM) response rate to chemotherapy is low. The identification of imaging biomarkers that could help guide the most effective therapy approach for individual patients is highly desirable. Our aim was to investigate the dynamic contrast-enhanced (DCE) MR...
Autores principales: | Vivoda Tomšič, Martina, Korošec, Peter, Kovač, Viljem, Bisdas, Sotirios, Šurlan Popovič, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859879/ https://www.ncbi.nlm.nih.gov/pubmed/35184730 http://dx.doi.org/10.1186/s12885-022-09277-x |
Ejemplares similares
-
Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria
por: Vivoda Tomšič, Martina, et al.
Publicado: (2019) -
Blood-brain barrier permeability imaging using perfusion computed tomography
por: Avsenik, Jernej, et al.
Publicado: (2015) -
Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021) -
Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017) -
Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
por: Ohashi, Akane, et al.
Publicado: (2023)